Thorn J J, Sørensen H, Weis-Fogh U, Andersen M
Department of Oral and Maxillofacial Surgery, University Hospital of Copenhagen, Rigshospitalet, Denmark.
Int J Oral Maxillofac Surg. 2004 Jan;33(1):95-100. doi: 10.1054/ijom.2003.0461.
The aim of this paper was to describe a method for the preparation of autologous fibrin glue with platelet growth factors and to report its use with particulate cancellous bone in reconstructive maxillofacial surgery. The fibrin glue is a two-component glue, where the one component is a concentrated fibrinogen solution with platelet growth factors and the other component is a thrombin solution. Both components were produced from the patients own blood, thus making the glue entirely autologous. The glue was prepared from platelet rich plasma separated from 200 ml of the patient's blood prior to the operation. The fibrinogen in the glue was precipitated from the platelet rich plasma by ethanol precipitation at low temperature and separated together with the platelets by centrifugation. Raising the temperature to 37 degrees C redissolved the precipitate. The thrombin solution in the glue was produced from prothrombin precipitated from 10 ml of the platelet rich plasma by lowering the pH and the ionic strength. The precipitate was separated by centrifugation and dissolved in a calcium ion solution. Increasing the pH to neutral value induced activation to thrombin. Preparation of the fibrin glue was performed in the blood bank within 60 to 90 min with the use of standard equipment. The outcome from 200 ml of blood was approximately 8 ml of fibrin glue: 6 ml fibrinogen to be coagulated with 2 ml of thrombin. The glue had a fibrinogen concentration of approximately 12 times the value in platelet rich plasma and the concentration of growth factors was approximately eight times the value in platelet rich plasma. We have used this glue successfully with particulate bone grafts for reconstructive purposes within the oral and maxillofacial field. It might as well be applied to other surgical areas. Whenever larger amount of the glue will be needed, a whole unit of blood may be taken from the patient, and the red cells re-transfused to the patient during or after the operation.
本文旨在描述一种制备含血小板生长因子的自体纤维蛋白胶的方法,并报告其在颌面重建手术中与颗粒状松质骨联合使用的情况。纤维蛋白胶是一种双组分胶水,其中一组分为含血小板生长因子的浓缩纤维蛋白原溶液,另一组分为凝血酶溶液。两组分均由患者自身血液制备,因此该胶水完全是自体的。该胶水由术前从200ml患者血液中分离出的富血小板血浆制备。胶水中的纤维蛋白原通过低温乙醇沉淀从富血小板血浆中析出,并通过离心与血小板一起分离。将温度升至37℃可使沉淀物重新溶解。胶水中的凝血酶溶液由通过降低pH值和离子强度从10ml富血小板血浆中沉淀出的凝血酶原制备。沉淀物通过离心分离并溶解于钙离子溶液中。将pH值调至中性可诱导其激活为凝血酶。纤维蛋白胶的制备在血库中使用标准设备在60至90分钟内完成。200ml血液可制备出约8ml纤维蛋白胶:6ml用于凝固的纤维蛋白原和2ml凝血酶。该胶水的纤维蛋白原浓度约为富血小板血浆中纤维蛋白原浓度的12倍,生长因子浓度约为富血小板血浆中生长因子浓度的8倍。我们已成功将这种胶水与颗粒状骨移植材料一起用于口腔颌面领域的重建目的。它也可应用于其他手术领域。每当需要大量胶水时,可从患者身上采集一单位全血,并在手术期间或术后将红细胞重新输回给患者。